- SEC delays ETF decisions; includes XRP, Dogecoin.
- TRX ETF receives regulatory approval from SEC.
- Market anticipates SEC approach shifts in near future.
The U.S. Securities and Exchange Commission (SEC) has postponed decisions on several cryptocurrency ETFs, including those for XRP and Dogecoin, while approving a TRX application. This delay was announced in Washington on May 20, 2025.
These developments highlight the SEC’s cautious approach to crypto ETFs, which could affect related market activities. Market participants are now assessing the short-term implications.
The SEC has postponed decisions on various cryptocurrency ETFs, such as those for XRP, Dogecoin, and Ethereum staking. This move was anticipated by analysts who suggest further delays could occur. In contrast, the TRX application has received approval, marking progress for Tron.
Affected stakeholders include investors and firms seeking exposure to these assets. The SEC aims to review proposals carefully, considering implications for market integrity. Key figures like Bloomberg’s James Seyffart have expressed expectations of further postponement.
“Delays on spot crypto ETFs are expected. A bunch of XRP ETPs have dates in next few days. If we’re gonna see early approvals from the SEC on any of these assets — I wouldn’t expect to see them until late June or early July at absolute earliest. More likely to be in early 4Q.” — James Seyffart, ETF Analyst, Bloomberg
The postponements may delay market entry for these ETFs, influencing investment strategies. Impacts are notable for assets like Ethereum and Dogecoin. This could influence associated markets and investor behavior in the coming months.
Delayed approvals could influence regulatory stances globally, affecting market conditions. With the SEC taking a meticulous approach, stakeholders must navigate potential changes in regulatory frameworks. The market’s focus now turns to the next SEC deadlines and possible outcomes.
Future ETF approval or denial will carry significant weight. Historical precedents suggest approvals have varied based on market conditions and regulatory priorities. Potential shifts in regulatory policies could emerge, contingent on market reactions and stakeholder lobbying.
